FLT3 signaling modulates PI3K/AKT and MAPK pathways, which are frequently dysregulated in CRC—and may influence tumor behavior via epigenetic or transcriptional mechanisms [26,27,28,29]. The gene discussed is FLT3; the disease is colorectal carcinoma.